Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07400198 · ClinicalTrials.gov registry record
Gait and Bone Health in SMA
A clinical trial of Spinal Muscular Atrophy Type 3 and Ambulatory Spinal Muscular Atrophy, sponsored by Jacqueline Montes.
- Recruiting
- Registry status
- 22
- Enrollment target
- 1
- Study location
NCT07400198 is a study of Spinal Muscular Atrophy Type 3 and Ambulatory Spinal Muscular Atrophy that is actively recruiting participants, run by Jacqueline Montes. The registered enrollment target is 22 participants, below the 93-participant average among 9 other Spinal Muscular Atrophy Type 3 trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07400198, a study of Spinal Muscular Atrophy Type 3 and Ambulatory Spinal Muscular Atrophy, is actively recruiting participants, sponsored by Jacqueline Montes.
- RECRUITING
- Registry status
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to understand how spatiotemporal and kinetic gait parameters are associated with bone health in pwSMA who are receiving DMT. We hypothesize that gait parameters are associated with BMD and can determine fracture risk in pwSMA. This is an observational study that involves one in-clinic visit (approximately 3 hours) with remote follow-up visits (approximately 15 minutes) every 3 months for 1 year to collect fracture and medical history. Each of the assessments included in this study are non-interventional and are not intended as a treatment nor are they at the level of standard of care.
Conditions Studied
Study Locations (1)
New York
- Columbia University Irving Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2026-03-05 |
| Est. Completion | 2027-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07400198
The ClinicalTrials.gov registry entry for NCT07400198 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 93-participant average among 9 other Spinal Muscular Atrophy Type 3 trials with a reported enrollment target (76% lower). The listed sponsor is Jacqueline Montes, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Spinal Muscular Atrophy Type 3 appearing as the primary indexed condition, and to 0 interventions.
NCT07400198 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT07400198 about?
NCT07400198 is a clinical study titled "Gait and Bone Health in SMA". The objective of this study is to understand how spatiotemporal and kinetic gait parameters are associated with bone health in pwSMA who are receiving DMT. We hypothesize that gait parameters are associated with BMD and can determine fracture risk in pwSMA. This is an observational study that involv...
What is the current status of trial NCT07400198?
This trial is currently recruiting. The enrollment target is 22 participants. The study started on 2026-03-05. Estimated completion is 2027-06-30.
What conditions does trial NCT07400198 study?
This clinical trial studies the following conditions: Spinal Muscular Atrophy Type 3, Ambulatory Spinal Muscular Atrophy.
Who is sponsoring clinical trial NCT07400198?
This trial is sponsored by Jacqueline Montes, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07400198 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Muscular Atrophy Type 3
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders
RECRUITING
-
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
RECRUITING · Phase 2
-
Spinal Cord Stimulation for the Treatment of Motor Deficits in People With Spinal Muscular Atrophy - Upper Limb
ACTIVE NOT RECRUITING · NA
-
Spinraza in Adult Spinal Muscular Atrophy
ACTIVE NOT RECRUITING
-
Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab
ACTIVE NOT RECRUITING · Phase 3
-
An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy
COMPLETED · Phase 2
Explore more on PlainTrial
Spinal Muscular Atrophy Type 3
All registered trials for this condition
Ambulatory Spinal Muscular Atrophy
All registered trials for this condition
New York
All trials with a study site in New York
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.